VIVO CAPITAL IX, LLC purchased 3.16M shares of IO BIOTECH, INC. on the open market
Open‑market purchase worth $6.00M. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/10/2023ACC: 0001213900-23-065297
+6.32M
Net shares
Net buyer
$6.00M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
6.32M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+3.16M
Price / share
$1.90
Trade value
$6M
% of position
New position
8/9/2023
0.00→3.16M
Total
Net shares
+3.16M
Net value
$6M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/9/2023 | P · Purchase | +3.16M | $1.90 | $6M | New position | 0.00 | 3.16M |
| Total | +3.16M | $6M | ||||||
Derivative Transactions1
Warrants (Right to Buy)
Indirect
Converts to
Common Stock
3.16M shares
Shares
+3.16M
Strike price
2.47
Held after
3.16M
Exercisable
—
8/9/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Indirect | Common Stock3.16M shares | 8/9/2023 | P · Purchase | +3.16M | 2.47 | — | 3.16M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.02M
Total
3.02M indirect3.02M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.02M | Indirect |
| Total | 3.02M | 3.02M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported